Bioworld Financial Watch articles from January 2003

Bioworld Financial Watch archives from January 2003

Antibiotics, antivirals still hold appeal for VCs in tight market.
January 6, 2003... Year-end retrospectives aside, taking the figurative pulse of an industry as large and varied as biotechnology is anything but easy. But during what everybody acknowledges were tight economic times, a notable trend was the continued interest by...

10 biggest U.S. gainers for the week.
January 6, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) MacroChem 62.39 Telik 1.48 Demegen 50.00 Gen-Probe 1.45 Ortec Int'l 42.86 VaxGen 1.44...

Grants and awards to biotech companies.
January 6, 2003... Grants And Awards To Biotech Companies: June -- Dec. 31, 2002 Company * Funding (Symbol) ** Institution 4SC AG * (Germany) European Union Aastrom Defense...

BioWorld stock report for public biotechnology companies.
January 6, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 12/27 1/3 WK YTD * 3D Pharma DDDP 3.1 3.15 ...

SBI, GeneFormatics merger mix of technologies, drugs--and cash.
January 13, 2003... In these hard economic times, when you hear anybody in biotechnology say it's "not all about cash," you might suspect the speaker of being naive or disingenuous. And when such words come out of the straitened genomics sector, they sound even...

10 biggest U.S. gainers & losers for the week.
January 13, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) OXiGENE 146.23 Sepracor 2.95 DOR BioPharma 60.38 IGEN 2.79 DeCode 49.25 NPS Pharma 2.68 Genz Mol...

Public financing of biotechnology.
January 13, 2003... Public Financing Of Biotechnology: December 2002 I. COMMENCED TRADING IN DECEMBER Company Date Date Shares/ Price Shares Lead, Gross Post- (Symbol) Filed Comm. Units Out Other (M) Offering ...

Other financings of public biotechnology companies.
January 13, 2003... Other Financings Of Public Biotechnology Companies: December 2002 TOTAL: $460.252M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies.
January 13, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: December 2002 1. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $227.12M Company Location Date Amt.(M) Amphora Research...

BioWorld stock report for Public Biotechnology Companies.
January 13, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/3 1/10 WK YTD 3D Pharma DDDP 3.15 3.11 ...

Money raised by biotech.
January 13, 2003... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1 - Dec. 31, Jan. 1 - Dec. 31, 2002: $10,247.17M 2001: $14,356M Public/Other * 5,631 ...

London Stock Exchange.
January 13, 2003... LONDON STOCK EXCHANGE Company Symbol 1/3 1/10 %WK %YTD Volume Acambis ACM 280.5 251 -10.52 -9.39 1699 Antisoma ASM 29.25 29.25 0.00 1.74 7063 British Biotech BBG ...

Toronto Stock Exchange.
January 13, 2003... TORONTO STOCK EXCHANGE Company Symbol 1/3 1/10 %WK %YTD Volume Adherex AHX 0.39 0.35 -10.26 -18.60 79 Angiotech Pharma ANP 56.45 53.5 -5.23 -0.13 181 Anormed ...

Panel favors Genzyme over TKT in fabry race fraught With irony.
January 20, 2003... Look up the origins of the word "enzyme" in the dictionary and you'll find it has a possible Greek root, related to the word "juice." Look up "juice," and you'll find that it can be defined as "strength, vigor, vitality" u words seldom...

10 biggest U.S. gainers & losers for the week.
January 20, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) 3D Pharma 81.35 Trimeris 3.89 Ista Pharma 70.34 Genzyme 3.83 Incara Pharma 65.00 Genentech ...

Clinical trial update.
January 20, 2003... Clinical Trial Update: December 2002 Company * Product Description (Country; Symbol) AUTOIMMUNE Alexion Eculizumab C5 complement inhibitor Pharmaceuticals Inc. (ALXN) ...

Non-U.S. clinical trials, regulatory submissions, recommendation and approvals.
January 20, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: December 2002 Company * (Country; Symbol) Product Description AUTOIMMUNE Amgen Inc. Enbrel Etanercept; tumor...

FDA submissions, approvals and other actions.
January 20, 2003... FDA Submissions, Approvals And Other Actions: December 2002 Company * Product (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel (AMGN) (FDA-approved) Cambridge...

BioWorld stock report for Public Biotechnology Companies.
January 20, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/10 1/17 WK YTD 3D Pharma DDDP 3.11 5.64 ...

London Stock Exchange.
January 20, 2003... LONDON STOCK EXCHANGE Company Symbol 1/10 1/17 %WK %YTD Volume Acambis ACM 251 244 -2.79 -11.91 2140 Antisoma ASM 29.25 27.75 -5.13 -3.48 5984 British Biotech BBG...

Toronto Stock Exchange.
January 20, 2003... TORONTO STOCK EXCHANGE Company Symbol 1/10 1/17 %WK %YTD Volume Adherex AHX 0.35 0.365 4.29 -15.12 80 Angiotech Pharma ANP 53.5 51.52 -3.70 -3.83 753 Anormed ...

Money raised by biotech.
January 20, 2003... Money Raised By Biotech In 2003 Vs. 2002 Millions Jan. 1 - Jan. 16, Jan. 1 - Jan. 17, 2003: $198.81M 2002: $268.443M Public/Other * 21 ...

Avant: case study of a defense deal helping keep firms healthy.
January 27, 2003... Some cynical Europeans might snicker about industry in America profiting from a threatened terrorist siege. Other commentators may marvel instead at company scientists' ability to engineer biodefense weapons. The editorial-page beat goes on....

Money raised by biotech.
January 27, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 -- Jan. 23, 2003: Jan. 1 -- Jan. 24, 2002: $458.8M $553.493M Public/Other * 50 313...

10 biggest U.S. gainers & losers for the week.
January 27, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Alteon 52.71 Genetronies 23.33 DOR BioPharma 21.50 Introgen 17.53 Genaissance 15.70 Cubist Pharma 13.88 Oxis Int'l...

U.S. public offering performance by underwriter.
January 27, 2003... U.S. Public Offering Performance By Underwriter: Jan. 1 - Dec. 31, 2002 * Underwriter Biotechnology Date Offering 12/31/02 Company priced price per Share ...

BioWorld stock report for public biotechnology companies.
January 27, 2003... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close 1/17 1/24 WK YTD ...